CD8A and liver cancer: Research has shown that suppression of CD8+ T cell exhaustion can hinder tumor development (Kumar et al. 2021), and clinical application of allogeneic γδ T cell immunotherapy has demonstrated prolonged survival in patients with advanced lung or liver cancer (Xu et al. 2021).